Defund the Wuhan Institute of Virology Act

Bill: 118-s-421
Sponsor: full_name: Sen. Ernst, Joni [R-IA]
Introduced: 2023-02-14
Policy area: International Affairs
Latest action: action_date: 2023-02-14
text: Read twice and referred to the Committee on Foreign Relations.

Summaries:
action_date: 2023-02-14
action_desc: Introduced in Senate
text: <p><strong>Defund the Wuhan Institute of Virology Act</strong></p> <p>This bill prohibits making federal funds available to the Wuhan Institute of Virology in China.</p> <p>The Government Accountability Office must report to Congress on federal funds that were provided directly or indirectly to the institute, the Chinese government, the Chinese Communist Party, or affiliates of these entities over the past 15 years.</p>

tv_txt: II 118th CONGRESS 1st Session S. 421 IN THE SENATE OF THE UNITED STATES February 14, 2023 Ms. Ernst introduced the following bill; which was read twice and referred to the Committee on Foreign Relations A BILL To prohibit Federal funding to the Wuhan Institute of Virology and to require a GAO study regarding Federal funds previously provided to such institute or to entities affiliated with the Chinese Government.

1. Short title This Act may be cited as the Defund the Wuhan Institute of Virology Act . 2. Prohibition on Federal funding to the Wuhan Institute of Virology (a) In general No funds authorized or appropriated by Federal law may be made available to the Wuhan Institute of Virology for any purpose. (b) GAO study and report Not later than 2 years after the date of the enactment of this Act, the Comptroller General of the United States shall conduct a study and submit a report to Congress regarding the amount of Federal funds that were awarded or indirectly provided (whether purposely or inadvertently) during the 15-year period immediately preceding such date of enactment to— (1) the Wuhan Institute of Virology, including affiliated researchers; (2) the People’s Republic of China; (3) the Chinese Communist Party; or (4) any agency or instrumentality of the entities listed in paragraphs (1) through (3).